Loading candles…
Sun Pharma Advanced Research Company Ltd, incorporated in 2007 as a spin-off from Sun Pharmaceutical Industries Ltd, operates as an independent research entity within the pharmaceutical and biopharmaceutical industries. The company specializes in the research and development of pharmaceutical products, focusing on novel therapies that include the discovery and development of new chemical entities (NCEs) and reformulated products tailored for global markets. Its primary therapeutic areas encompass oncology, immunology, and neurology.
| Date |
|---|
| Audited Results - Q4 & FY26 | To consider and approve the Audited Financial Results for the Quarter and Financial Year ended March 31, 2026 | 18 May 2026 |
| Unaudited Results - Q3-FY25 | To consider and approve the Unaudited Financial Results of the Company for the Quarter and Nine Months ended December 31, 2025 | 9 Feb 2026 |
| Fund Raising | To consider Fund Raising through Preferential Allotment | 14 Jan 2026 |
| Unaudited Results - Q2 & FY25 | Sun Pharma Advanced Research Company Limited has informed the exchange about Board Meeting to be held on 10-Nov-2025 to inter-alia consider and approve the U… | 10 Nov 2025 |
| Results - FY25 | To consider and approve the financial results for the period ended Jun 30, 2025 | 4 Aug 2025 |
| Results - FY25 | To consider and approve the financial results for the period ended March 31, 2025 | 19 May 2025 |
Besseggen InfoTech LLP is a SEBI-registered stock broker (Reg. No. INZ000213450), member of NSE (90155 (Cash & F&O)) and BSE (6722 (Cash & F&O)). Investment in securities market are subject to market risks; read all related documents carefully before investing.